States Move to Limit Access to H.I.V. Treatment

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.This week, thousands of Floridians were cut off from benefits that make H.I.V. medications more affordable. The medication Biktarvy was also dropped from Florida’s formulary.